What are the appropriate admitting orders for a patient with hypertensive cerebellar hemorrhage?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Admitting Orders for Hypertensive Cerebellar Hemorrhage

Admit this patient to a neurological ICU with continuous BP monitoring and hourly neurological assessments, targeting systolic BP 130-150 mm Hg with IV nicardipine or other rapidly titratable agent, obtain immediate neurosurgical consultation given the high risk of obstructive hydrocephalus and brainstem compression, and obtain repeat head CT at 6 and 24 hours to assess for hematoma expansion. 1, 2

Critical Initial Actions

Location and Monitoring

  • Admit to Neurological ICU - Cerebellar hemorrhages require specialized monitoring due to the tight posterior fossa compartment with minimal space to accommodate mass effect 2
  • Continuous cardiac monitoring
  • Hourly neurological assessments with GCS documentation
  • Continuous BP monitoring with arterial line placement

Immediate Imaging and Neurosurgical Evaluation

  • Urgent neurosurgical consultation - This is non-negotiable for cerebellar hemorrhage given the risk of obstructive hydrocephalus and brainstem compression 2, 3
  • Baseline non-contrast head CT (already obtained)
  • Repeat head CT at 6 hours and 24 hours after onset to detect hematoma expansion, which occurs in 26% of patients at 1 hour and additional 12% at 20 hours 1
  • Consider CTA if within 2 hours of onset to assess for spot sign (predictor of hematoma expansion) 1

Blood Pressure Management

Target and Timing

Target SBP: 130-150 mm Hg - This is the safe range for mild-to-moderate ICH with presenting SBP 150-220 mm Hg 1

Critical timing considerations:

  • Initiate treatment within 2 hours of ICH onset
  • Reach target within 1 hour to reduce hematoma expansion risk 1
  • Avoid SBP <130 mm Hg - This is potentially harmful and associated with worse outcomes 1

Antihypertensive Agent

  • IV nicardipine (preferred) - continuous infusion for smooth, sustained control
    • Start at 5 mg/hr, titrate by 2.5 mg/hr every 5-15 minutes
    • Maximum 15 mg/hr
  • Alternative: IV labetalol boluses (10-20 mg IV push, double dose every 10 minutes to max 300 mg)
  • Avoid large BP variability - High SBP variability in first 24 hours is linearly associated with death and severe disability 1

Airway and Respiratory Management

  • NPO status initially
  • Assess airway protection and GCS
  • Intubate if GCS ≤8 or signs of impending herniation 4
  • Elevate head of bed 30 degrees

Reversal of Coagulopathy

  • Check PT/INR, aPTT, platelet count immediately
  • If on warfarin: 4-factor PCC + IV vitamin K 10 mg
  • If on DOACs: specific reversal agents (idarucizumab for dabigatran, andexanet alfa for Xa inhibitors)
  • Do NOT transfuse platelets if on antiplatelet therapy unless surgical evacuation planned 4

Management of Intracranial Pressure

For Small Hematoma (<30 cc) Without Mass Effect

  • No routine mannitol or hypertonic saline 4
  • Monitor clinically

For Large Hematoma (>30 cc) or Symptomatic Edema

  • Target serum sodium 140-150 mEq/L for 7-10 days to minimize edema expansion 4
  • Hypertonic saline 3% continuous infusion via central line (preferred over mannitol)
  • Bolus 23.4% HTS for acute deterioration or pending herniation 4

Ventriculostomy Indications

  • Obstructive hydrocephalus from fourth ventricle compression (common in cerebellar hemorrhage) 4, 3
  • Elevated ICP refractory to medical management
  • Severe intraventricular hemorrhage extension

Surgical Considerations

Cerebellar hemorrhage has specific surgical indications that differ from supratentorial ICH:

  • Emergent surgical evacuation indicated for:

    • Hematoma >3 cm diameter
    • Neurological deterioration
    • Brainstem compression
    • Obstructive hydrocephalus 4, 2, 5
  • Note: The 2022 AHA/ASA guidelines state that safety and efficacy of intensive BP lowering are not well established in patients requiring surgical decompression 1 - maintain close communication with neurosurgery regarding BP targets if surgery is planned

Seizure Prophylaxis

  • No routine seizure prophylaxis - not beneficial 4
  • Treat only if clinical or electrographic seizures occur

VTE Prophylaxis

  • Intermittent pneumatic compression devices - start immediately on admission 4
  • Subcutaneous heparin 5000 units q8-12h - start within 48 hours if patient is stable and no hematoma expansion on repeat imaging 4

Additional Orders

  • Serum sodium, osmolality q6h if using hypertonic saline
  • Blood glucose q4h - maintain <180 mg/dL (no benefit to aggressive control) 4
  • Temperature monitoring - treat fever >38.3°C but no benefit to aggressive management 4
  • Stool softener to prevent Valsalva
  • Foley catheter
  • Type and screen

Common Pitfalls to Avoid

  1. Delaying neurosurgical consultation - Cerebellar hemorrhage can deteriorate rapidly due to posterior fossa anatomy 2, 3
  2. Lowering BP too aggressively (<130 mm Hg) - This is harmful 1
  3. Missing obstructive hydrocephalus - Requires urgent ventriculostomy 3
  4. Admitting to general medical floor - These patients require neurological ICU level care 4
  5. Not obtaining repeat imaging - 38% of hematoma expansion occurs in first 20 hours 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.